KRAS and lung carcinoma: Therefore, we assumed that the inhibitory effects of verteporfin in KRAS-mutant lung cancer cell proliferation were related to EMT-related mechanisms, but we did not observe a clear relationship between the effects of verteporfin and EMT in this study.